Enhabit (NYSE:EHAB – Get Free Report) is expected to be announcing its Q2 2025 earnings results after the market closes on Wednesday, August 6th. Analysts expect the company to announce earnings of $0.10 per share and revenue of $263.39 million for the quarter. Enhabit has set its FY 2025 guidance at 0.410-0.510 EPS.
Enhabit (NYSE:EHAB – Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.03. The firm had revenue of $259.90 million during the quarter, compared to analyst estimates of $266.11 million. Enhabit had a positive return on equity of 2.02% and a negative net margin of 13.43%. On average, analysts expect Enhabit to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Enhabit Price Performance
EHAB opened at $6.64 on Tuesday. The stock has a 50-day moving average price of $8.52 and a 200-day moving average price of $8.57. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.49 and a quick ratio of 1.49. The firm has a market cap of $336.00 million, a PE ratio of -2.40 and a beta of 1.68. Enhabit has a 1 year low of $6.47 and a 1 year high of $10.90.
Hedge Funds Weigh In On Enhabit
Enhabit Company Profile
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
Featured Articles
- Five stocks we like better than Enhabit
- What is Insider Trading? What You Can Learn from Insider Trading
- Analysts Make a Quantum Bet on D-Wave’s Cryogenic Packaging
- How to Profit From Value Investing
- Traders Turn Bullish on Housing Stocks Again—3 Leading the Way
- How to invest in marijuana stocks in 7 steps
- Onsemi’s August Pullback Is a Signal to Buy for Tech Investors
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.